Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Frequent mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) and the promoter of telomerase reverse transcriptase (TERT) represent two significant discoveries in glioma genomics. Understanding the degree to which these two mutations co-occur or occur exclusively of one another in glioma su...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Killela, Patrick J., Pirozzi, Christopher J., Healy, Patrick, Reitman, Zachary J., Lipp, Eric, Rasheed, B. Ahmed, Yang, Rui, Diplas, Bill H., Wang, Zhaohui, Greer, Paula K., Zhu, Huishan, Wang, Catherine Y., Carpenter, Austin B., Friedman, Henry, Friedman, Allan H., Keir, Stephen T., He, Jie, He, Yiping, McLendon, Roger E., Herndon II, James E., Yan, Hai, Bigner, Darell D.
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2014
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4039228/
https://ncbi.nlm.nih.gov/pubmed/24722048
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires